European agency rejects Serostim
BY Advocate.com Editors
May 01 2003 12:00 AM ET
The European Medicines Evaluations Agency on Monday announced that its scientific committee has rejected an application by Serono to market its anti-wasting drug Serostim to AIDS patients in Europe. The drug is approved for the treatment of AIDS-related wasting in the United States. In a statement, the agency said there was concern about the long-term safety of the medication and that long-term efficacy data also was lacking. Serostim is a recombinant human growth hormone that has been shown to increase muscle mass in those taking the medication.
- WATCH: Ireland's New Marriage Equality Ad Will Give You Goosebumps
- Pa. Students Allegedly Throw 'Anti-Gay Day,' Write 'Lynch List'
- Scott Eastwood: 'I Support Gay Marriage'
- WATCH: Russian Army Sings 'Barbie Girl'
- Bryan Cranston: 'End This Silliness' of Opposing Marriage Equality
- World Goes Bonkers On Antigay Michigan Repairman